IGC Pharma (IGC) EBITDA Margin Growth (1y) (2011 - 2025)
IGC Pharma (IGC) EBITDA Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | -1,651.00 |
| 10 | IGC Pharma | 30.43 Mn | 30.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -109,062.00 |
| Jun 30, 2025 | 30,009.00 |
| Mar 31, 2025 | 30,741.00 |
| Dec 31, 2024 | 73,887.00 |
| Sep 30, 2024 | 42,883.00 |
| Jun 30, 2024 | -49,548.00 |
| Mar 31, 2024 | 169,754.00 |
| Dec 31, 2023 | -78,346.00 |
| Sep 30, 2023 | 37,567.00 |
| Jun 30, 2023 | 93,629.00 |
| Mar 31, 2023 | 289,556.00 |
| Dec 31, 2022 | 99,343.00 |
| Sep 30, 2022 | 653,260.00 |
| Jun 30, 2022 | 152,765.00 |
| Mar 31, 2022 | -188,301.00 |
| Dec 31, 2021 | 47,413.00 |
| Sep 30, 2021 | -642,349.00 |
| Jun 30, 2021 | -251,870.00 |
| Mar 31, 2021 | 497,846.00 |
| Dec 31, 2020 | -186,086.00 |